Medicated Intrauterine Devices

Present day IUDs are a critical part of family arranging administrations and an astounding prophylactic decision for appropriately screened ladies, giving contraception that is sheltered, successful, durable and financially savvy. Potential research procedures for what's to come are likewise talked about. Only 2 types of medicated IUDs have been extensively tested in women - the IUD releasing copper and the IUD releasing progesterone. Modifying the IUD by adding a pharmacologically active agent to the inert device was attempted to order to reduce its side effects and increase its efficacy. The drug can act through an effect on the pituitary-ovarian axis, inhibiting ovulation; on spermatazoa, inhibiting implantation; on the endometrium, making it hostile to the implanting ovum; or on uterine motility or luteal activity, thus working as an abortifacient. These various mechanisms of action are reviewed, followed by a group and general discussion.

 

 

  • Track 1-1 Uterine Geometry and IUD Performance
  • Track 2-2 The Effect of the IUD on the Ultrastructure of the Endometrium
  • Track 3-3 Physiological Mechanisms of IUDs
  • Track 4-4 Pituitary-Ovarian Function in IUD Users
  • Track 5-5 Intrauterine Contraception with the Progestasert

Related Conference of Medical